Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids

ABSTRACT Gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is used as a confirmation procedure for detecting the administration of synthetic forms of endogenous anabolic androgenic steroids (EAAS) by comparing the carbon isotope ratios ( δ 13 C) of target compounds (TCs) with those of endogenous reference compounds (ERCs). In recent years, some samples have been found to still contain interfering matrix components in different TC/ERC fractions after HPLC purification, which can rapidly deactivate the GC/C/IRMS reactor. 1‐(2,6‐Dichlorophenyl)indolin‐2‐one (1‐(DCP)I) has been identified as a major contributor to reactor deactivation. Subsequent studies suggested that 1‐(DCP)I was associated with diclofenac (DCF), a major metabolite formed following DCF sodium administration. DCF can persist in target fractions even after purification by one‐ or two‐dimensional semipreparative liquid chromatography coupled with fraction collection. During subsequent GC/C/IRMS analysis, residual chlorinated substances in purified fractions may contribute to oxidation reactor deactivation, thereby interfering with the determination of analyte ‘s δ 13 C values. Optimization of the backflush time in the GC/C/IRMS system can effectively minimize the influence of these chlorine‐containing substances on analysis.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2026-11-13
DOI
https://doi.org/10.1002/dta.70179
Primary Topic
Doping in Sports
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids

Tianshuo Zhu, 王占良, Chao Wen, Kuan Yan et al.
Drug Testing and Analysis
Doping in Sports
article

Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids

Tianshuo Zhu, 王占良, Chao Wen, Kuan Yan, Mengmeng Yan, Ma Congcong
article en

Abstract

ABSTRACT Gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is used as a confirmation procedure for detecting the administration of synthetic forms of endogenous anabolic androgenic steroids (EAAS) by comparing the carbon isotope ratios ( δ 13 C) of target compounds (TCs) with those of endogenous reference compounds (ERCs). In recent years, some samples have been found to still contain interfering matrix components in different TC/ERC fractions after HPLC purification, which can rapidly deactivate the GC/C/IRMS reactor. 1‐(2,6‐Dichlorophenyl)indolin‐2‐one (1‐(DCP)I) has been identified as a major contributor to reactor deactivation. Subsequent studies suggested that 1‐(DCP)I was associated with diclofenac (DCF), a major metabolite formed following DCF sodium administration. DCF can persist in target fractions even after purification by one‐ or two‐dimensional semipreparative liquid chromatography coupled with fraction collection. During subsequent GC/C/IRMS analysis, residual chlorinated substances in purified fractions may contribute to oxidation reactor deactivation, thereby interfering with the determination of analyte ‘s δ 13 C values. Optimization of the backflush time in the GC/C/IRMS system can effectively minimize the influence of these chlorine‐containing substances on analysis.

Drug Testing and Analysis
Beijing Sport University (CN)
Doping in Sports
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon